The Medical Letter on Drugs and Therapeutics
In Brief: Duration of Use of Bisphosphonates
October 3, 2011 (Issue: 1374)The FDA and two of its advisory committees have been debating whether to recommend limiting the duration of use of bisphosphonates in order to prevent atypical femoral fractures and possibly other side effects of the drugs. The agency produced a...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.